D-Index & Metrics Best Publications
Research.com 2022 Best Female Scientist Award Badge

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 123 Citations 59,013 629 World Ranking 1367 National Ranking 43
Best female scientists D-index 123 Citations 59,014 711 World Ranking 304 National Ranking 7

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Female Scientist Award

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Surgery
  • Disease

Her scientific interests lie mostly in Internal medicine, Rheumatoid arthritis, Surgery, Ankylosing spondylitis and Randomized controlled trial. The study incorporates disciplines such as Placebo and Physical therapy in addition to Internal medicine. Her Rheumatoid arthritis research is multidisciplinary, relying on both Methotrexate, Gastroenterology, Erythrocyte sedimentation rate, Connective tissue disease and Combination therapy.

Her research in Surgery intersects with topics in Epidemiology, Infliximab and Immunopathology. The concepts of her Ankylosing spondylitis study are interwoven with issues in BASDAI, Clinical trial, Cohort and Syndesmophyte. The various areas that Désirée van der Heijde examines in her Randomized controlled trial study include Physical exercise, Functional ability, Adverse effect and Disease-modifying antirheumatic drug.

Her most cited work include:

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update (3784 citations)
  • Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial (1047 citations)
  • Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis (985 citations)

What are the main themes of her work throughout her whole career to date?

Her primary areas of study are Internal medicine, Rheumatoid arthritis, Ankylosing spondylitis, Physical therapy and Rheumatology. Her Internal medicine research includes themes of Gastroenterology, Placebo and Surgery. Her Rheumatoid arthritis course of study focuses on Radiography and Joint damage.

Her study in the field of Spondylitis also crosses realms of In patient. Désirée van der Heijde focuses mostly in the field of Physical therapy, narrowing it down to topics relating to Clinical trial and, in certain cases, Observational study. Her study in Rheumatology is interdisciplinary in nature, drawing from both Orthopedic surgery, Pathology and Rheumatoid factor.

She most often published in these fields:

  • Internal medicine (58.91%)
  • Rheumatoid arthritis (33.87%)
  • Ankylosing spondylitis (33.07%)

What were the highlights of her more recent work (between 2017-2021)?

  • Internal medicine (58.91%)
  • Ankylosing spondylitis (33.07%)
  • Axial spondyloarthritis (14.61%)

In recent papers she was focusing on the following fields of study:

Her primary areas of investigation include Internal medicine, Ankylosing spondylitis, Axial spondyloarthritis, Radiography and Rheumatoid arthritis. Her work on Rheumatology, Cohort and Spondylitis as part of general Internal medicine study is frequently linked to In patient, bridging the gap between disciplines. Her Ankylosing spondylitis research is multidisciplinary, relying on both Quality of life, BASDAI, Syndesmophyte, Severity of illness and Confounding.

The concepts of her Axial spondyloarthritis study are interwoven with issues in Physical therapy, Certolizumab pegol and Family medicine. The study incorporates disciplines such as Rheumatism, Methotrexate, Disease and Arthritis in addition to Rheumatoid arthritis. Her work focuses on many connections between Placebo and other disciplines, such as Randomized controlled trial, that overlap with her field of interest in Tofacitinib.

Between 2017 and 2021, her most popular works were:

  • Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force (293 citations)
  • TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort (138 citations)
  • Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis. (130 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Surgery

Désirée van der Heijde mainly focuses on Internal medicine, Ankylosing spondylitis, Placebo, Rheumatoid arthritis and In patient. Her research links Radiography with Internal medicine. Her Ankylosing spondylitis research is multidisciplinary, incorporating perspectives in Magnetic resonance imaging, Axial spondyloarthritis, Severity of illness and Outcomes research.

The Placebo study combines topics in areas such as Randomized controlled trial, Antibody and Phases of clinical research. Her research integrates issues of Rheumatism, Methotrexate, Disease and Intensive care medicine in her study of Rheumatoid arthritis. Her Clinical trial research includes elements of Psoriatic arthritis, Arthritis and Adverse effect.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch.
Annals of the Rheumatic Diseases (2014)

3425 Citations

Treating rheumatoid arthritis to target: recommendations of an international task force

Josef S. Smolen;Daniel Aletaha;Johannes W J W Bijlsma;Ferdinand C Breedveld.
Annals of the Rheumatic Diseases (2010)

2471 Citations

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Josef S. Smolen;Robert Landewé;Ferdinand C Breedveld;Maxime Dougados.
Annals of the Rheumatic Diseases (2010)

2195 Citations

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang.
Arthritis & Rheumatism (2011)

1541 Citations

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

Maarten Boers;Arco C Verhoeven;Harry M Markusse;Mart Afj van de Laar.
The Lancet (1997)

1527 Citations

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial

E William St Clair;Désirée M F M van der Heijde;Josef S Smolen;Ravinder N Maini.
Arthritis & Rheumatism (2004)

1487 Citations

Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis

Ernst Feldtkeller;Muhammad Asim Khan;Désirée van der Heijde;Sjef van der Linden.
Rheumatology International (2003)

954 Citations

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

Désirée van der Heijde;Sofia Ramiro;Robert Landewé;Xenofon Baraliakos.
Annals of the Rheumatic Diseases (2017)

951 Citations

Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial

Astrid Wanders;Désirée van der Heijde;Robert Landewé;Jéhan-Michel Béhier.
Arthritis & Rheumatism (2005)

874 Citations

COBRA Combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention

Robert B. M. Landewé;Maarten Boers;Arco C. Verhoeven;Rene Westhovens.
Arthritis & Rheumatism (2002)

825 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Désirée van der Heijde

Paul Emery

Paul Emery

University of Leeds

Publications: 336

Maxime Dougados

Maxime Dougados

Hôpital Cochin

Publications: 251

Josef S. Smolen

Josef S. Smolen

Medical University of Vienna

Publications: 220

Mikkel Østergaard

Mikkel Østergaard

University of Copenhagen

Publications: 218

Laure Gossec

Laure Gossec

Sorbonne University

Publications: 180

Yoshiya Tanaka

Yoshiya Tanaka

University of Occupational and Environmental Health Japan

Publications: 179

Philip J. Mease

Philip J. Mease

University of Washington

Publications: 178

Robert Landewé

Robert Landewé

University of Amsterdam

Publications: 171

Joachim Sieper

Joachim Sieper

Charité - University Medicine Berlin

Publications: 170

Tore K. Kvien

Tore K. Kvien

University of Oslo

Publications: 161

Tsutomu Takeuchi

Tsutomu Takeuchi

Keio University

Publications: 148

Bernard Combe

Bernard Combe

University of Montpellier

Publications: 145

Maarten Boers

Maarten Boers

Vrije Universiteit Amsterdam

Publications: 145

Walter P. Maksymowych

Walter P. Maksymowych

University of Alberta

Publications: 138

Daniel Aletaha

Daniel Aletaha

Medical University of Vienna

Publications: 138

Tom W. J. Huizinga

Tom W. J. Huizinga

Leiden University Medical Center

Publications: 138

Trending Scientists

John Stasko

John Stasko

Georgia Institute of Technology

Mohamed Abdel-Mottaleb

Mohamed Abdel-Mottaleb

University of Miami

David Hummels

David Hummels

Purdue University West Lafayette

Ken-ichi Kitayama

Ken-ichi Kitayama

Osaka University

Tadafumi Adschiri

Tadafumi Adschiri

Tohoku University

Yasukazu Yoshida

Yasukazu Yoshida

National Institute of Advanced Industrial Science and Technology

Serena Sanna

Serena Sanna

University Medical Center Groningen

Philippe Lashermes

Philippe Lashermes

University of Montpellier

Annalea Lohila

Annalea Lohila

Finnish Meteorological Institute

Dietrich Lehmann

Dietrich Lehmann

University of Zurich

Carol McDonald Connor

Carol McDonald Connor

University of California, Irvine

Katsuto Shinohara

Katsuto Shinohara

University of California, San Francisco

David Couper

David Couper

University of North Carolina at Chapel Hill

Howard B. Moss

Howard B. Moss

National Institutes of Health

Matthew Chinman

Matthew Chinman

RAND Corporation

Bogdan Povh

Bogdan Povh

Max Planck Society

Something went wrong. Please try again later.